Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)
4.5600
-0.9900 (-17.84%)
NASDAQ · Last Trade: Sep 18th, 1:48 PM EDT
Detailed Quote
Previous Close
5.550
Open
4.400
Bid
4.560
Ask
4.620
Day's Range
4.230 - 4.660
52 Week Range
4.500 - 108.00
Volume
1,227,987
Market Cap
204.19M
PE Ratio (TTM)
-1.572
EPS (TTM)
-2.9
Dividend & Yield
N/A (N/A)
1 Month Average Volume
272,215
Chart
About Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)
Salarius Pharmaceuticals is a clinical-stage biotechnology company focused on developing innovative therapies for cancer patients. The company specializes in the research and development of novel drug candidates that target specific epigenetic mechanisms to combat various forms of cancer. By harnessing the potential of these targeted therapies, Salarius aims to improve treatment outcomes and minimize side effects for patients. The company's approach emphasizes precision medicine, with a commitment to addressing unmet medical needs in oncology through robust scientific innovation and clinical trials. Read More
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Specificity Inc. (OTCID: SPTY), a next-generation digital marketing firm, has regained its status as a fully reporting SEC current filer—marking a key milestone as it continues to revolutionize audience targeting across digital platforms. Known for eliminating bots and irrelevant impressions, Specificity’s proprietary ad tech delivers precision-targeted ads across display, social, and Connected TV (CTV) to the same verified, high-intent audiences —maximizing ROI and minimizing waste.
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
